Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Tips for Treating Lupus-Related Renal Disease, Pain, Alopecia

Susan Bernstein  |  Issue: January 2018  |  January 19, 2018

“Whatever treatments are on the horizon, don’t be afraid to tell patients that they have a powerfully painful disorder that will get better, but slowly, and that there’s no guarantee that the first, second or even third agent that we use will help,” he said. “I know that sounds negative, but I find that it resonates with patients, because they’ve likely been down this road before. Be bold and creative, and try polysymptomatic approaches.”

Alopecia

Hair loss is commonly seen in lupus patients, but not all alopecia types are the same, said Victoria P. Werth, MD, pro­fessor of dermatology at the Hospital of the University of Pennsylvania in Philadelphia. Rheumatologists may encounter lupus->specific alopecia, lupus-nonspecific alopecia or alopecia unrelated to their lupus at all. Alopecia is included in the new ACR/EULAR classification criteria for SLE.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

“Lupus-specific alopecia is something I think we’re all very familiar with in these patients. They usually have underlying erythema and scale, and it’s associated with lesions that are due to discoid lupus, sub-acute cutaneous lupus or acute SLE,” said Dr. Werth. Patients may have dispigmentation, permanent hair loss and follicular plugging.

Lupus-nonspecific alopecia is non-scarring. These patients may have “lupus hairs,” or coarse, dry, fragile, very short hairs on the scalp along the forehead. “This can include diffuse areas of non-scarring alopecia which waxes and wanes with systemic disease activity, and can be a manifestation of the telogen effluvium [temporary hair loss] that is not specific to lupus, but we see plenty of it in our SLE patients.”

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

About 10% of SLE patients have alopecia arreata unrelated to their disease. These patients have circular, totally hairless patches, but no erythema or scale. Their telogen effluvium may happen postpartum, after surgery or due to stress, she said. Some SLE patients also have androgenic alopecia, or typical male- or female-pattern baldness.

Patients with subacute cutaneous lupus or acute SLE may have a temporary hair loss followed by regrowth later, she said. Using a magnifying lens or dermatoscope, loss of follicular ostia can be seen, which means the hair loss is permanent, she said.

Biopsy on a horizontal section of the scalp is one way to diagnose the alopecia type. “Look for the changes of lupus in the skin, look at the different follicles to see what happened to them, and check for follicular scarring,” which means hair is not regrowing and is likely telogen-related, she said.

Incidence is unclear, but lupus-nonspecific alopecia may affect up to 40% of SLE patients. In these cases, hair often regrows when disease activity is controlled. These patients may have short, thin hair along with typical lupus flare symptoms. Medication may also cause this temporary hair loss.

Page: 1 2 3 4 | Single Page
Share: 

Filed under:ConditionsMeeting ReportsSystemic Lupus Erythematosus Tagged with:AC&RACR/ARHP Annual MeetingalopeciaAmerican College of Rheumatology (ACR)LupusPainpatient careRenalrheumatologistTreatment

Related Articles

    Causes of Alopecia Can Vary Among Patients with Systemic Disease Say Experts at the 2013 ACR/ARHP Annual Meeting

    March 1, 2014

    Beyond such autoimmune diseases as systemic lupus erythematosus and rheumatoid arthritis, rheumatologists should consider hypothyroidism, dietary issues, and grooming habits in patients with hair loss

    Hair dye being applied to a man’s beard.

    Case Report: A 50-Year-Old Man Suffers Dye-Induced Arthritis

    December 18, 2019

    Hair dye products are commonly used by both men and women to enhance youth and beauty and to follow fashion trends. As reported in the medical literature, hair dyes and their ingredients are associated with allergic contact dermatitis. A possible association with joint inflammation has also been recognized. There is literature to support that para-phenylenediamine…

    State-of-the-Art Approaches to Rheumatic Disease Diagnosis, Management & Treatment

    March 19, 2019

    CHICAGO—Held during the 2018 ACR/ARHP Annual Meeting, the ACR Review Course covered a wide range of topics for rheumatologists—from advances in pain and rheumatic disease management to the intersection of rheumatology and neurology. Session speakers shared insights, as well as state-of-the-art approaches to diagnosis, management and treatment. Inflammatory Myopathies Julie J. Paik, MD, MHS, assistant…

    TNF Blockade for SLE

    September 1, 2010

    Reckless approach versus missed opportunity?

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences